Kenya runs out of Johnson & Johnson vaccine

On Monday, the government announced that Kenya has run out of the single-shot Johnson and Johnson vaccine.

Speaking during the #SemaNaSpox session, Government Spokesman Cyrus Oguna said that as of December 3, Kenya had a total of 3,472,500 in stock, at the Central Vaccine Store in Kitengela.

Of these vaccines, Moderna had 70,560, AstraZeneca (2,492,500), Pfizer (739,440), Sinopharm (170,000), while Johnson and Johnson was out of stock.

As of December 5, Kenya had so far vaccinated 7,583,134. Out of these, 4,628,299 are first doses, while 2,954,835.

The government targets to have at least 10 million Kenyans vaccinated by end of December.

This was boosted by the reduction of the vaccination age bracket to begin at 15 years for those with access to the Pfizer vaccine.

Oguna said the economy will fully reopen when Kenyans will have been able to protect themselves and others from the different virus variants by getting the jab.

"Getting vaccinated could save your life. The COVID-19 vaccines provide you with strong protection against serious illness, hospitalization and death from contracting the virus," he said.

Edited by D Tarus